Macrogenics (MGNX) Treasury Shares (2012 - 2026)

Macrogenics (MGNX) reported Treasury Shares of $19000.0 for Q1 2015, little changed quarter-over-quarter from $19000.0 in Q4 2014.

Macrogenics (MGNX) Treasury Shares (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 4 years of Treasury Shares data on file, last reported at $19000.0 in Q1 2015.

  • Treasury Shares for Q1 2015 came in at $19000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2015 was $19000.0 (changed N/A YoY), and the FY2014 annual result was $19000.0, down 67.24% from the prior year.
  • Treasury Shares steadied at $19000.0 in Q1 2015 per MGNX's latest filing, from $19000.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $1.1 million in Q1 2024 and troughed at $307308.0 in Q2 2022.
  • A 5-year average of $824259.1 and a median of $908277.0 in 2023 frame the typical range for Treasury Shares.
  • The sharpest annual moves came in 2013 and 2014: Treasury Shares climbed 0.45% in 2013, then plunged 67.24% in 2014.
  • A 4-year view of Treasury Shares shows it stood at $57742.0 in 2012, then grew by 0.45% to $58000.0 in 2013, then sank by 67.24% to $19000.0 in 2014, then changed by 0.0% to $19000.0 in 2015.
  • Business Quant data shows MGNX's Treasury Shares at $19000.0 in Q1 2015, $19000.0 in Q4 2014, and $58000.0 in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 700,000.00
9 Abivax 91.96 Bn 91.96 Bn - -
10 Macrogenics 260.14 Mn 193.63 Mn - 980,613.00

Historic Data

Download Data
DateValue
Mar 31, 2026 980,613.00
Mar 31, 2026 980,613.00
Dec 31, 2025 745,796.00
Dec 31, 2025 745,796.00
Sep 30, 2025 837,216.00
Sep 30, 2025 837,216.00
Jun 30, 2025 849,239.00
Jun 30, 2025 849,239.00
Mar 31, 2025 955,649.00
Mar 31, 2025 955,649.00
Dec 31, 2024 1.07 Mn
Dec 31, 2024 1.07 Mn
Sep 30, 2024 1.05 Mn
Sep 30, 2024 1.05 Mn
Jun 30, 2024 1.12 Mn
Jun 30, 2024 1.12 Mn
Mar 31, 2024 1.12 Mn
Mar 31, 2024 1.12 Mn
Dec 31, 2023 905,614.00
Dec 31, 2023 905,614.00